BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 112 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,000 | 0.0% | 1,300 | -43.5% | 0.00% | – |
| Q1 2017 | $4,000 | +100.0% | 2,300 | +76.9% | 0.00% | – |
| Q4 2016 | $2,000 | -77.8% | 1,300 | -60.6% | 0.00% | – |
| Q3 2016 | $9,000 | +80.0% | 3,300 | +43.5% | 0.00% | – |
| Q2 2016 | $5,000 | -28.6% | 2,300 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -36.4% | 2,300 | 0.0% | 0.00% | – |
| Q4 2015 | $11,000 | +450.0% | 2,300 | +666.7% | 0.00% | – |
| Q3 2015 | $2,000 | -50.0% | 300 | -15.5% | 0.00% | – |
| Q1 2015 | $4,000 | -50.0% | 355 | -45.8% | 0.00% | – |
| Q4 2014 | $8,000 | +60.0% | 655 | +118.3% | 0.00% | – |
| Q3 2014 | $5,000 | +25.0% | 300 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q1 2014 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q4 2013 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 2,000,000 | $7,820,000 | 6.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $37,262,000 | 0.78% |
| EMC Capital Management | 193,906 | $758,000 | 0.54% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,486,454 | $13,632,000 | 0.50% |
| ALGERT GLOBAL LLC | 344,210 | $1,346,000 | 0.43% |
| Hillsdale Investment Management Inc. | 877,000 | $3,430,000 | 0.29% |
| Stanley-Laman Group, Ltd. | 349,465 | $1,366,000 | 0.22% |
| SHEPHERD KAPLAN KROCHUK, LLC | 94,000 | $368,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 178,474 | $698,000 | 0.13% |
| Zebra Capital Management LLC | 23,622 | $92,000 | 0.10% |